SLC5A2 and heart failure: Although the beneficial effects of SGLT2 inhibitors on heart failure outcomes have been demonstrated consistently, their impact on some of the other cardiovascular outcomes are less apparent, owing to mixed evidence from RCTs and limited observational studies.